Status:
UNKNOWN
Extracorporeal Membrane Oxygenation Evaluated by Transcranial Doppler.
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Extracorporeal Membrane Oxygenation Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine how venoarterial extracorporeal membrane oxygenation (ECMO) affects cerebral blood flow velocity (CBFV) measured by transcranial doppler (TCD), to determine whether specific changes in ce...
Detailed Description
Venoarterial Extracorporeal membrane oxygenation (ECMO) is used in adult with refractory cardiac failure as a life-saving measure. Adults treated with ECMO survived to hospital discharge in 21,8% to 6...
Eligibility Criteria
Inclusion
- adult patient who receiving ECMO therapy
Exclusion
- cervico-encephalic vasculopathy
- lacked an acoustic window allowing for adequate TCD examination
- stroke in medical past.
Key Trial Info
Start Date :
April 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03457090
Start Date
April 5 2018
End Date
September 1 2020
Last Update
April 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059